A care team, not a comment thread.
Nouri is an independent editorial site. We do not prescribe, dispense, or sell medication; we compare licensed GLP-1 providers and their published prices, and may earn a commission. This archived page covers what to ask about clinician support when you compare providers.
Nouri no longer offers its own GLP-1 program. Compare current options: cheapest GLP-1 prices, best compounded GLP-1 providers, or GLP-1 dose calculators.
Compounded GLP-1s are not FDA-approved. Safety info →
Nouri no longer offers its own GLP-1 program. Compare current options: cheapest GLP-1 prices, best compounded GLP-1 providers, or GLP-1 dose calculators.
Compounded semaglutide is not FDA-approved. The FDA does not verify the safety, effectiveness, or quality of compounded drugs. Compounded medications are prepared based on a prescription from a licensed provider for a specific patient.
GLP-1 medications require a prescription after a medical evaluation by a licensed healthcare provider. Not all patients are eligible. Treatment decisions are made by licensed providers based on individual medical history.
Important Safety InformationThe science is real.
average body-weight reduction in clinical trials of the branded GLP-1 medications semaglutide and tirzepatide — achieved alongside a structured nutrition and movement plan.
Compounded semaglutide is not FDA-approved; the FDA does not verify the safety, effectiveness, or quality of compounded drugs. Compounded medications are prepared based on a prescription from a licensed provider for a specific patient. The figures above are averages from clinical trials of the branded GLP-1 medications, not of any compounded product. GLP-1 medications target the brain’s appetite signals and work best alongside a nutrition and activity plan, per the NIDDK and the Endocrine Society. Individual results vary and are not typical.
Important Safety InformationSwitching, care, and billing: common questions
- I’m already on a GLP-1 with another provider. Can I switch?
- Usually, yes. Nouri no longer offers its own GLP-1 program. If you switch providers, give the new prescriber your current medication, dose, and history so they can plan your start from where you are — not from zero. Not everyone qualifies.
- Are telehealth clinicians real people?
- Nouri no longer offers its own GLP-1 program or clinician messaging. When you compare providers, ask whether U.S.-licensed clinicians answer your messages and whether messaging is included in the price.
- How does the billing work?
- Nouri no longer offers its own GLP-1 program, so there is no Nouri subscription or refund term. Check each provider’s own billing, cancellation and refund policy before you join.
- What is included in a GLP-1 program?
- Nouri no longer offers its own GLP-1 program. What a provider’s price covers varies, so ask whether it includes the medication, clinician messaging, dose changes, and nutrition guidance. Compare current options in our cheapest GLP-1 cost comparison, our guide to the best compounded GLP-1 providers, or our GLP-1 dose calculators.
- What happens if side effects hit at week two?
- Message your prescriber — they can adjust your titration. Nausea, vomiting, diarrhea, and constipation are the most common GLP-1 side effects and usually ease as the dose is increased gradually. People with a personal or family history of medullary thyroid carcinoma or MEN2 should not take GLP-1s.
- How much does GLP-1 treatment cost?
- Nouri no longer offers its own GLP-1 program. Prices vary by provider and medication; compare current options in our cheapest GLP-1 cost comparison or our guide to the best compounded GLP-1 providers.
- Are compounded GLP-1s FDA-approved?
- No. Compounded semaglutide and tirzepatide are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or manufacturing quality. They are prepared by a licensed 503A compounding pharmacy against an individual prescription, which is permitted under federal law. They are not equivalent to the FDA-approved brand-name drugs Wegovy, Ozempic, Zepbound, or Mounjaro.
Medically reviewed by Amber Patel, MD · Last reviewed June 30, 2026
References
- Wilding JPH, Batterham RL, Calanna S, et al; STEP 1 Study Group. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384(11):989–1002. doi:10.1056/NEJMoa2032183
- Jastreboff AM, Aronne LJ, Ahmad NN, et al; SURMOUNT-1 Investigators. Tirzepatide once weekly for the treatment of obesity. N Engl J Med. 2022;387(3):205–216. doi:10.1056/NEJMoa2206038